China Pharma Holdings, Inc. also files under CPHI.OB; those filings are included. Filings under CPHI by Mortgage TR Systematic Invt Pfas Of Mortgage Trust Corp (CIK 0000110664) from Oct 13, 2009 to Apr 28, 2012 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 29, 2023 | Li Zhilin | CEO & Interim CFO, Director, 10% Owner | Grant(A) | 13.8M | $0.14 | $1.9M |
| Sep 9, 2021 | Li Zhilin | CEO & Interim CFO, Director, 10% Owner | Grant(A) | 1.8M | $0.67 | $1.2M |
| Dec 23, 2020 | Li Zhilin | CEO and interim CFO, Director, 10% Owner | Grant(A) | 2.0M | — | $0 |
| Apr 28, 2012 | Waung Frank | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| May 25, 2011 | Li Zhilin | President and CEO, Director, 10% Owner | Grant(A) | 50K | — | $0 |
| May 25, 2011 | Waung Frank | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| May 25, 2011 | Li Zhilin | President and CEO, Director, 10% Owner | Grant(A) | 25K | — | $0 |
| May 25, 2011 | Waung Frank | Chief Financial Officer | Disposed to issuer(D) | 25K | — | $0 |
| May 25, 2011 | Waung Frank | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| Dec 13, 2010 | Waung Frank | Chief Financial Officer | Grant(A) | 7K | — | $0 |
| Nov 15, 2010 | Waung Frank | Chief Financial Officer | Option exercise(M) | 4K | — | — |
| Nov 15, 2010 | Waung Frank | Chief Financial Officer | Option exercise(M) | 40K | — | — |
| Apr 28, 2010 | Waung Frank | Chief Financial Officer | Disposed to issuer(D) | 150K | — | $0 |
| Apr 28, 2010 | Waung Frank | Chief Financial Officer | Grant(A) | 200K | — | — |
| Feb 9, 2010 | Tsui Heung Mei | Director, 10% Owner | Grant(A) | 1.5M | $3.00 | $4.5M |
| Oct 13, 2009 | Waung Frank | Chief Financial Officer | Disposed to issuer(D) | 10K | — | $0 |
| Oct 13, 2009 | Waung Frank | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Oct 13, 2009 | Waung Frank | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Nov 6, 2007 | Tsui Heung Mei | Director, 10% Owner | Grant(A) | 4.5M | $1.52 | $6.8M |
| Sep 13, 2006 | Li Zhilin | President and CEO, Director, 10% Owner | Grant(A) | 10.0M | — | — |
| Sep 13, 2006 | Tsui Heung Mei | Director, 10% Owner | Grant(A) | 10.0M | — | — |
| May 16, 2006 | Tsui Heung Mei | Director, 10% Owner | Grant(A) | 4.7M | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: China Pharma Holdings, Inc., SEC CIK 0001106644. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CPHI and shows every filing by that issuer (also filed as CPHI.OB). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for CPHI